Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

5:15 PM - 6:15 PM PT

Hem 3: Radiating Precision: Tailoring Therapy for Lymphoma, Leukemia, and Myeloma
Speaker: Nabavizadeh, Nima, MD - Oregon Health & Science University, Portland, OR
5:15 PM - 6:15 PM PT

Radiation and Cancer Biology 5: Cellular Radiation Effects & DNA damage response
Speaker: Pitter, Kenneth, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
5:20 PM - 5:25 PM PT

1078 - <em>Re</em>duced-vo<em>l</em>ume Irradiation to the <em>Ax</em>illa in Breast Cancer Patients with Sentinel-Lymph-Node Metastases (RELAX): A Single-Arm, Phase 2 Study
Speaker: Luo, Jurui, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
5:20 PM - 5:25 PM PT

1084 - Prospective Phase II Trial of Short Course Androgen Deprivation, Pelvic SBRT, and Brachytherapy Boost for NCCN High-Risk Prostate Cancer with Low-Intermediate Risk Decipher Genomic Score
Speaker: Goglia, Alexander, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
5:20 PM - 5:25 PM PT

1090 - Variance in Practice Patterns among Radiation Oncologists Treating Oropharyngeal Cancers
Speaker: Bailey, Morgan, MD - University of Cincinnati - Barrett Cancer Center, Cincinnati, OH
5:20 PM - 5:25 PM PT

1096 - Multimodal Imaging of the Functional and Physiological Bone Marrow Microenvironment in AML: Toward Personalized Clinical Applications
Speaker: Hui, Susanta, PhD - City of Hope National Medical Center, Duarte, CA
5:20 PM - 5:25 PM PT

1102 - CDCA3 Promotes Radiotherapy Resistance in Lung Adenocarcinoma by Facilitating Non-Homologous End Joining
Speaker: Lai, Tangmin, MS - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, Chongqing
5:20 PM - 5:25 PM PT

1103 - SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models
Speaker: Megahed, Romy, MD - UAMS Radiation Oncology, Little Rock, AR
5:25 PM - 5:30 PM PT

1079 - Effect of Radiation Dose on Lymphedema Development Following Immediate Lymphatic Reconstruction and Axillary Lymph Node Dissection
Speaker: Spiegel, Daphna, MD, MS - Brigham and Women's Hospital/Dana-Farber Cancer Institute , Boston, Massachusetts
5:25 PM - 5:30 PM PT

1085 - A Phase I/Ib, Single Arm Study of Two Fraction SBRT with SIB for the Treatment of Localized Prostate Cancer: Early Toxicity Outcomes
Speaker: Lischalk, Jonathan, MD - Georgetown University School of Medicine, Washington, DC
5:25 PM - 5:30 PM PT

1091 - HYPCON 03 Pilot Study: A Study Exploring Delivery of 3Gy per Fraction in Post Operative Radiotherapy for Head and Neck Carcinomas
Speaker: Sharma, Aman, MD, DO, DSc - All India Institute of Medical Sciences, Healthcare, Practitioner and Technician, Delhi
5:25 PM - 5:30 PM PT

1097 - Response Rate and Local Control of Response-Adapted Very Low Dose Radiotherapy (RA-VLDRT) with 4 Gy for Indolent Non-Hodgkin Lymphoma
Speaker: Mankuzhy, Nikhil, MD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ